Early trial tests bold new combo to fight advanced cancer spread
NCT ID NCT07453875
Summary
This early-stage study is testing the safety of a new combination treatment for people with stomach or colon cancer that has spread to the lining of the abdomen. The treatment involves low-dose radiation to the whole abdomen, followed by a mix of chemotherapy and immunotherapy drugs delivered directly into the abdomen. The main goal is to see if this multi-step approach is safe and tolerable for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LDRT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Army Medical Center
Chongqing, Chongqing Municipality, 400042, China
-
Daping Hospital, Army Medical University
Chongqing, Chongqing Municipality, 400042, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.